Skip to content
Clinical Trials – home
Research site

Meditsinski Tsentar Arkus Medikal A.D.

Bulgaria Nish 1, 5002 Veliko Tirnovo, Bulgaria

  • 2 trials recruiting
  • Metabolic dysfunction-associated steatohepatitis · Non-alcoholic steatohepatitis · Autoimmune hepatitis
  • Adult patients

About Specializations

Meditsinski Tsentar Arkus Medikal A.D. in Veliko Tirnovo, Bulgaria specialises in clinical trials of conditions such as Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, Autoimmune hepatitis, Colitis ulcerative, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

The research team at Meditsinski Tsentar Arkus Medikal A.D. is conducting a trial focused on ulcerative colitis, aiming to assess a new therapy’s ability to induce and maintain clinical remission.

  • Induction therapy strategies
  • Maintenance of remission
  • Evaluation of patient-reported outcomes
  • Comparative effectiveness versus placebo

This work supports advances in digestive health and offers hope for patients with moderately to severely active disease.

Immune System Phenomena

A separate study at the same facility examines the safety profile of a novel monoclonal antibody in individuals with autoimmune hepatitis, focusing on tolerability and adverse event monitoring.

  • Comprehensive safety assessments
  • Tolerability over multiple dosing cycles
  • Liver function biomarker tracking
  • Placebo-controlled comparative analysis

Findings aim to expand therapeutic options for immune‑mediated liver disease and improve patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Recruiting now
2 trials
Conditions studied
4

More sites in Veliko TirnovoBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

Autoimmune hepatitis

Not yet recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Inebilizumab
  • Sponsor:Amgen Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.